Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

Abstract Introduction Tralokinumab and dupilumab are biological agents licensed for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients who are candidates for systemic treatment. However, no head-to-head studies of their efficacy have been conducted. This study indirectly co...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Tiago Torres, Anne Sohrt Petersen, Ulla Ivens, Albert Bosch Vilaro, John Stinson, José Manuel Carrascosa
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Adis, Springer Healthcare 2024-04-01
Saila:	Dermatology and Therapy
Gaiak:	Atopic dermatitis Dupilumab Matching-adjusted indirect comparison Topical corticosteroids Tralokinumab
Sarrera elektronikoa:	https://doi.org/10.1007/s13555-024-01143-x
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!